MedGyn's Thermal Ablation System Hits the International Market

Battery-powered Cervical Cancer Treatment

In 2019, the World Health Organization (WHO) issued new guidelines for the use of thermal ablation for cervical pre-cancer lesions. While they continue to recommend cryotherapy, the WHO has offered thermal ablation as an alternative method of treatment for specific environments.

MedGyn is pleased to introduce the MedGyn MTA-100 Thermal Ablation System: a portable, lightweight device for the treatment of pre-cancerous lesions optimized for 20, 40, or 60 second intervals of treatment.

Product Features

Optimized to offer 20, 40, or 60 second internals for procedure

Bright LED lights for clear viewing of cervical area

Digital display to detailing temperature at all stages of procedure

Durable and ergonomic handle for ease of use

25mm tip available offering larger treatment area (5 types of interchangeable gold alloy tips)

Sound and light activation for beginning and end of procedure

Patent Pending